The perception and management of drug safety risks /
| Άλλοι συγγραφείς: | , |
|---|---|
| Μορφή: | Βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Berlin, Heidelberg ; New York :
Springer Berlin Heidelberg,
1989.
|
| Σειρά: | Health Systems Research ;
1431-4002 |
| Θέματα: |
Πίνακας περιεχομένων:
- Opening Address
- I: Society and the Benefit/Risk Relationship
- 1. Acceptable Risk in Society
- 2. A Broad Framework for Confronting Health Risks
- 3. Communicating the Risks and Benefits of Technology: The Case of Pharmaceuticals
- 4. Overview of the Drug Safety Issue and Ciba-Geigy’s Response: RAD-AR
- 5. Summary of Part I: Presentations and Discussions
- II: Benefit/Risk Analysis and Appraisal
- 6. Limitations of Available Sources of Data on Prescription Drug Safety
- 7. Strategies, Designs, Criteria, Tactics and Statistics to be Considered when Evaluating Scientific Evidence
- 8. Statistics in Drug Risk Research: The Background of Pharmacoepidemiology
- 9. Industry-Sponsored Risk Institutes
- 10. The Feldene Experience: A Case Study
- 11. Risk Perception of Prescription Drugs: Report on a Survey in Sweden
- 12. Risk Perception of Prescription Drugs: Report on Surveys in Japan
- 13. Scientific and Political Components of Regulatory Decision Making: General Considerations
- 14. Scientific and Political Components of Regulatory Decision Making: The United States Experience
- 15. Summary of Part II: Presentations and Discussions
- III: Current Challenges
- 16. Professional Drug Information: A Consumer Perspective
- 17. Going Patient, Going Public
- 18. Reporting Adverse Drug Reactions: The Media Approach
- 19. What Can Be Learned from Drug Safety Issues?
- 20. Summary of Part III: Presentations and Discussions
- IV: Responding to the Issues
- 21. Editor’s Note
- 22. Pharmacoepidemiology
- 23. Risk Perception Analysis
- 24. Communicating the Benefit/Risk Relationship
- 25. Risk Appraisal on an International Scale
- V: Outlook
- 26. The Wolfsberg Questions
- VI: Annex
- 27. Curriculum Vitae of Authors
- 28. Bibliography
- 29. Subject Index
- 30. A Handbook of International Data Sources for Drug Benefit/Risk Assessment.